Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus
暂无分享,去创建一个
A. Boonen | V. Strand | D. Furst | V. Bykerk | C. Bingham | R. Christensen | E. Choy | C. Pohl | S. Bartlett | A. Leong | T. Woodworth | R. Alten | S. Hewlett | T. Sanderson | Amye Leong
[1] J. Singh,et al. Developing a provisional definition of flare in patients with established gout. , 2012, Arthritis and rheumatism.
[2] M. D. de Wit,et al. The importance of patient participation in measuring rheumatoid arthritis flares , 2012, Annals of the rheumatic diseases.
[3] M. Calnan,et al. Utilizing Qualitative Data from Nominal Groups: Exploring the Influences on Treatment Outcome Prioritization with Rheumatoid Arthritis Patients , 2012, Journal of Health Psychology.
[4] F. Guillemin,et al. A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: The ‘FLARE’ instrument , 2011, Annals of the rheumatic diseases.
[5] M. Cross,et al. 'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought. , 2012, Rheumatology.
[6] V. Strand,et al. Developing a Construct to Evaluate Flares in Rheumatoid Arthritis: A Conceptual Report of the OMERACT RA Flare Definition Working Group , 2011, The Journal of Rheumatology.
[7] P. Brooks,et al. Identifying Preliminary Domains to Detect and Measure Rheumatoid Arthritis Flares: Report of the OMERACT 10 RA Flare Workshop , 2011, The Journal of Rheumatology.
[8] M. Dougados,et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative , 2011, Annals of the rheumatic diseases.
[9] M. D. de Wit,et al. Treating rheumatoid arthritis to target: the patient version of the international recommendations , 2011 .
[10] M. Urowitz,et al. International consensus for a definition of disease flare in lupus , 2011, Lupus.
[11] P. Tugwell,et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. , 2011, Arthritis and rheumatism.
[12] M. D. de Wit,et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects , 2011, Annals of the Rheumatic Diseases.
[13] M. Calnan,et al. Patient perspective of measuring treatment efficacy: The rheumatoid arthritis patient priorities for pharmacologic interventions outcomes , 2010, Arthritis care & research.
[14] S. Brophy,et al. Frequency and characteristics of disease flares in ankylosing spondylitis , 2010, Rheumatology.
[15] V. Strand,et al. “Flare” and disease worsening in rheumatoid arthritis: Time for a definition , 2009 .
[16] Mahboob Rahman,et al. Developing a Standardized Definition for Disease “Flare” in Rheumatoid Arthritis (OMERACT 9 Special Interest Group) , 2009, The Journal of Rheumatology.
[17] R. Shewchuk,et al. Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. , 2009, Arthritis and rheumatism.
[18] M. Dougados,et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative , 2008, Annals of the rheumatic diseases.
[19] A. Cieza,et al. Responsiveness of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis , 2008, Annals of the rheumatic diseases.
[20] P Tugwell,et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. , 2008, Arthritis and rheumatism.
[21] P. Dieppe,et al. Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. , 2008, Rheumatology.
[22] F. Wolfe,et al. The challenges of determining RA disease activity and remission in clinical practice , 2008, Nature Clinical Practice Rheumatology.
[23] F. Wolfe,et al. The problem of rheumatoid arthritis disease activity and remission in clinical practice. , 2008, The Journal of rheumatology.
[24] M. Suarez‐Almazor,et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. , 2007, The Journal of rheumatology.
[25] P. Voulgari,et al. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. , 2006, Seminars in arthritis and rheumatism.
[26] M. Dougados,et al. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. , 2005, Rheumatology.
[27] E. Taal,et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. , 2003, The Journal of rheumatology.
[28] A. Calin,et al. Definition of disease flare in ankylosing spondylitis: the patients' perspective. , 2002, The Journal of rheumatology.
[29] E. Giannini,et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis. , 2002, The Journal of rheumatology.
[30] J J Anderson,et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials , 1993 .
[31] R. Brook,et al. Consensus methods: characteristics and guidelines for use. , 1984, American journal of public health.